Psychedelic drugs have great therapeutic benefit if understood on their own terms | Ross Ellenhorn and Dimitri MugianisAn advisory panel rejected MDMA-assisted therapy for PTSD, impacting FDA approval of ecstasy. The rejection is viewed as a significant setback for the psychedelic movement.